Academic Journal

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases

التفاصيل البيبلوغرافية
العنوان: Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
المؤلفون: Raman, SR, Man, KKC, Bahmanyar, S, Berard, A, Bilder, S, Boukhris, T, Bushnell, G, Crystal, S, Furu, K, KaoYang, Y-H, Karlstad, O, Kieler, H, Kubota, K, Lai, EC-C, Martikainen, JE, Maura, G, Moore, N, Montero, D, Nakamura, H, Neumann, A, Pate, V, Pottegard, A, Pratt, NL, Roughead, EE, Saint-Gerons, DM, Sturmer, T, Su, C-C, Zoega, H, Sturkenbroom, MCJM, Chan, EW, Coghill, D, Ip, P, Wong, ICK
المصدر: The Lancet Psychiatry , 5 (10) pp. 824-835. (2018)
بيانات النشر: ELSEVIER SCI LTD
سنة النشر: 2018
المجموعة: University College London: UCL Discovery
الوصف: BACKGROUND: The use of medications to treat attention deficit hyperactivity disorder (ADHD) has increased, but the prevalence of ADHD medication use across different world regions is not known. Our objective was to determine regional and national prevalences of ADHD medication use in children and adults, with a specific focus on time trends in ADHD medication prevalence. METHODS: We did a retrospective, observational study using population-based databases from 13 countries and one Special Administrative Region (SAR): four in Asia and Australia, two in North America, five in northern Europe, and three in western Europe. We used a common protocol approach to define study populations and parameters similarly across countries and the SAR. Study populations consisted of all individuals aged 3 years or older between Jan 1, 2001, and Dec 31, 2015 (dependent on data availability). We estimated annual prevalence of ADHD medication use with 95% CI during the study period, by country and region and stratified by age and sex. We reported annual absolute and relative percentage changes to describe time trends. FINDINGS 154·5 million individuals were included in the study. ADHD medication use prevalence in 2010 (in children aged 3–18 years) varied between 0·27% and 6·69% in the countries and SAR assessed (0·95% in Asia and Australia, 4·48% in North America, 1·95% in northern Europe, and 0·70% in western Europe). The prevalence of ADHD medication use among children increased over time in all countries and regions, and the absolute increase per year ranged from 0·02% to 0·26%. Among adults aged 19 years or older, the prevalence of any ADHD medication use in 2010 varied between 0·003% and 1·48% (0·05% in Asia and Australia, 1·42% in North America, 0·47% in northern Europe, and 0·03% in western Europe). The absolute increase in ADHD medication use prevalence per year ranged from 0·0006% to 0·12%. Methylphenidate was the most commonly used ADHD medication in most countries. INTERPRETATION: Using a common protocol and data from 13 ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: text
اللغة: English
Relation: https://discovery.ucl.ac.uk/id/eprint/10058682/3/Raman_Man_ADHD_medication_20180713.pdf; https://discovery.ucl.ac.uk/id/eprint/10058682/6/Wong_Appendix_Table%20A1toA9_201807012.pdf; https://discovery.ucl.ac.uk/id/eprint/10058682/15/Wong_ADHD_trend_TABLES_20180711%20%282%29.pdf; https://discovery.ucl.ac.uk/id/eprint/10058682/
الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10058682/3/Raman_Man_ADHD_medication_20180713.pdf
https://discovery.ucl.ac.uk/id/eprint/10058682/6/Wong_Appendix_Table%20A1toA9_201807012.pdf
https://discovery.ucl.ac.uk/id/eprint/10058682/15/Wong_ADHD_trend_TABLES_20180711%20%282%29.pdf
https://discovery.ucl.ac.uk/id/eprint/10058682/
Rights: open
رقم الانضمام: edsbas.71D387A2
قاعدة البيانات: BASE